Literature DB >> 1866415

Peripheral chemoreceptor reflex in obstructive sleep apnea patients; a relationship between ventilatory response to hypoxia and nocturnal bradycardia during apnea events.

M Tafil-Klawe1, A E Thiele, F Raschke, J Mayer, J H Peter, W von Wichert.   

Abstract

15 patients with obstructive sleep apnea syndrome and arterial hypertension (H-OSAS), 25 normotensive patients with sleep apnea syndrome (N-OSAS) and 20 healthy age-matched controls (C) were included in this study. Ventilatory responses to activation (hypoxia) and inactivation (hyperoxia) of carotid chemoreceptors were studied in all subjects. Relationship between hypoxic ventilatory reactivity and nocturnal bradycardia during apnea-phases was analysed in both groups of patients. Results and conclusions. 1. We found an impairment of ventilatory response to hypoxia in H-OSAS and N-OSAS patients. However, the increase in ventilation in response to hypoxia was significantly greater in H-OSAS as compared to N-OSAS patients. 2. An augmented ventilatory response to inactivation of carotid chemoreceptors (the decrease in ventilation), observed in H-OSAS patients, indicates an increase in resting peripheral chemoreceptors drive in this group of patients. 3. The relationship between ventilatory response to hypoxia and nocturnal bradycaria in obstructive sleep apnea patients suggests, that hypoxic reactivity of arterial chemoreceptors might be involved in the origin of bradycardia during apnea events.

Entities:  

Mesh:

Year:  1991        PMID: 1866415

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  14 in total

1.  The hypoxic ventilatory response and ventilatory long-term facilitation are altered by time of day and repeated daily exposure to intermittent hypoxia.

Authors:  David G Gerst; Sanar S Yokhana; Laura M Carney; Dorothy S Lee; M Safwan Badr; Tabarak Qureshi; Magalie N Anthouard; Jason H Mateika
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

Review 2.  Peripheral chemoreceptors: function and plasticity of the carotid body.

Authors:  Prem Kumar; Nanduri R Prabhakar
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

Review 3.  Carotid body chemoreflex: a driver of autonomic abnormalities in sleep apnoea.

Authors:  Nanduri R Prabhakar
Journal:  Exp Physiol       Date:  2016-08-01       Impact factor: 2.969

4.  Loss of excitatory amino acid transporter restraint following chronic intermittent hypoxia contributes to synaptic alterations in nucleus tractus solitarii.

Authors:  Diana Martinez; Richard C Rogers; Eileen M Hasser; Gerlinda E Hermann; David D Kline
Journal:  J Neurophysiol       Date:  2020-04-29       Impact factor: 2.714

Review 5.  Peripheral chemoreception and arterial pressure responses to intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Ganesh K Kumar; Jayasri Nanduri
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

Review 6.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 7.  Sensing hypoxia: physiology, genetics and epigenetics.

Authors:  Nanduri R Prabhakar
Journal:  J Physiol       Date:  2013-03-04       Impact factor: 5.182

Review 8.  Long-term regulation of carotid body function: acclimatization and adaptation--invited article.

Authors:  N R Prabhakar; Y-J Peng; G K Kumar; J Nanduri; C Di Giulio; Sukhamay Lahiri
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

9.  Determinants of ventilatory instability in obstructive sleep apnea: inherent or acquired?

Authors:  Andrea Loewen; Michele Ostrowski; John Laprairie; Raj Atkar; January Gnitecki; Patrick Hanly; Magdy Younes
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

Review 10.  Intermittent hypoxia and respiratory plasticity in humans and other animals: does exposure to intermittent hypoxia promote or mitigate sleep apnoea?

Authors:  Jason H Mateika; Gunjan Narwani
Journal:  Exp Physiol       Date:  2008-12-05       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.